U.S., Canadian Pharma-Bio Industry Sees Year-Over-Year Project Spending Uptick in Second Quarter
U.S., Canadian Pharma-Bio Industry Sees Year-Over-Year Project Spending Uptick in Second Quarter
SUGAR LAND--May 12, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The COVID-19 pandemic has wreaked havoc upon all manufacturing sectors, not only in North America, but all global regions. Pharmaceutical/biotech manufacturing saw no exception to this impediment, mainly due to overreliance on global supply chains (e.g. active pharmaceutical ingredients-APIs). However, the pharma/biotech manufacturing demographic has led the charge in the economic recovery in U.S. and Canada manufacturing, and is expected to remain robust with an upward trajectory.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion